DINGO: Differential network analysis in genomics

Bioinformatics

Volumn 31, Issue 21, 2015, Pages 3413-3420

  Ha, Min Jin ^a   Baladandayuthapani, Veerabhadran ^a   Do, Kim Anh ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA;

ALGORITHM; COMPUTER SIMULATION; COPY NUMBER VARIATION; DNA METHYLATION; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORK; GENETICS; GENOMICS; GLIOBLASTOMA; HUMAN; PROCEDURES; REGRESSION ANALYSIS; SIGNAL TRANSDUCTION; THEORETICAL MODEL;

ALGORITHMS; COMPUTER SIMULATION; DNA COPY NUMBER VARIATIONS; DNA METHYLATION; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; GENOMICS; GLIOBLASTOMA; HUMANS; MICRORNAS; MODELS, THEORETICAL; REGRESSION ANALYSIS; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84947554993     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/btv406     Document Type: Article

References (48)

1. Allen,J.D. et al. (2012) Comparing statistical methods for constructing large scale gene networks. PLoS One, 7, e29348.
2. Bandyopadhyay,S. et al. (2010) Rewiring of genetic networks in response to DNA damage. Science, 330, 1385-1389.
3. Banerjee,O. et al. (2008) Model selection through sparse maximum likelihood estimation for multivariate Gaussian or binary data. J. Machine Learning Res., 9, 485-516.
4. Barabási,A.-L. and Albert,R. (1999) Emergence of scaling in random networks. Science, 286, 509-512.
5. Boehm,J.S. and Hahn,W.C. (2011) Towards systematic functional characterization of cancer genomes. Nat. Rev. Genet., 12, 487-498.
6. Califano,A. (2011) Rewiring makes the difference. Mol. Syst. Biol., 7, 463.
7. Cao,Y. et al. (2011) Cancer research: past, present and future. Nat. Rev. Cancer, 11, 749-754.
8. Dang,C.V. et al. (2009) MYC-induced cancer cell energy metabolism and therapeutic opportunities. Clin. Cancer Res., 15, 6479-6483.
9. de la Fuente,A. (2010) From differential expression to differential networking - identification of dysfunctional regulatory networks in diseases. Trends Genet., 26, 326-333.
10. Fan,J. et al. (2009) Network exploration via the adaptive lasso and scad penalties. Ann. Appl. Stat., 3, 521.
11. Flintoft,L. (2004) Rewiring the network. Nat. Rev. Genet., 5, 808-808.
12. Friedman,J. et al. (2008) Sparse inverse covariance estimation with the graphical lasso. Biostatistics, 9, 432-441.
13. Furnari,F.B. et al. (2007) Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev., 21, 2683-2710.
14. Goeman,J.J. and Bühlmann,P. (2007) Analyzing gene expression data in terms of gene sets: methodological issues. Bioinformatics, 23, 980-987.
15. Hoff,P.D. and Niu,X. (2012) A covariance regression model. Stat. Sin., 22, 729-753.
16. Hudson,N.J. et al. (2009) A differential wiring analysis of expression data correctly identifies the gene containing the causal mutation. PLoS Comput. Biol., 5, e1000382.
17. Ideker,T. and Krogan,N.J. (2012) Differential network biology. Mol. Syst. Biol., 8, 565.
18. Khatri,P. et al. (2012) Ten years of pathway analysis: current approaches and outstanding challenges. PLoS Comput. Biol., 8, e1002375.
19. Lauritzen,S.L. (1996) Graphical Models. Oxford University Press, USA.
20. Liu,B.-H. et al. (2010) DCGL: an R package for identifying differentially coexpressed genes and links from gene expression microarray data. Bioinformatics, 26, 2637-2638.
21. Liu,R. et al. (2008) Cdk5-mediated regulation of the PIKE-A-Akt pathway and glioblastoma cell invasion. Proc. Natl. Acad. Sci. USA, 105, 7570-7575.
22. Luscombe,N.M. et al. (2004) Genomic analysis of regulatory network dynamics reveals large topological changes. Nature, 431, 308-312.
23. Markowetz,F. and Spang,R. (2007) Inferring cellular networks - a review. BMC Bioinformatics, 8, S5.
24. Masui,K. et al. (2013) mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc. Cell Metab., 18, 726-739.
25. McLendon,R. et al. (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature, 455, 1061-1068.
26. Miller,K.S. (1981) On the inverse of the sum of matrices. Math. Mag., 54, 67-72.
27. Mischel,P.S. and Cloughesy,T.F. (2003) Targeted molecular therapy of GBM. Brain Pathol., 13, 52-61.
28. Mitra,K. et al. (2013) Integrative approaches for finding modular structure in biological networks. Nat. Rev. Genet., 14, 719-732.
29. Mitrea,C. et al. (2013) Methods and approaches in the topology-based analysis of biological pathways. Front. Physiol., 4, 278.
30. Moncini,S. et al. (2011) The role of miR-103 and miR-107 in regulation of CDK5R1 expression and in cellular migration. PLoS One, 6, e20038.
31. Nebert,D.W. (2000) Extreme discordant phenotype methodology: an intuitive approach to clinical pharmacogenetics. Eur. J. Pharmacol., 410, 107-120.
32. Rahmatallah,Y. et al. (2014) Gene sets net correlations analysis (GSNCA): a multivariate differential coexpression test for gene sets. Bioinformatics, 30, 360-368.
33. Reverter,A. et al. (2006) Simultaneous identification of differential gene expression and connectivity in inflammation, adipogenesis and cancer. Bioinformatics, 22, 2396-2404.
34. Rhinn,H. et al. (2013) Integrative genomics identifies APOE ε4 effectors in Alzheimer's disease. Nature, 500, 45-50.
35. Rothman,A.J. et al. (2008) Sparse permutation invariant covariance estimation. Electron. J. Stat., 2, 494-515.
36. Schadt,E.E. (2009) Molecular networks as sensors and drivers of common human diseases. Nature, 461, 218-223.
37. Tarca,A.L. et al. (2009) A novel signaling pathway impact analysis. Bioinformatics, 25, 75-82.
38. Tavazoie,S. et al. (1999) Systematic determination of genetic network architecture. Nat. Genet., 22, 281-285.
39. Taylor,I.W. et al. (2009) Dynamic modularity in protein interaction networks predicts breast cancer outcome. Nat. Biotechnol., 27, 199-204.
40. Tesson,B.M. et al. (2010) Diffcoex: a simple and sensitive method to find differentially coexpressed gene modules. BMC Bioinformatics, 11, 497.
41. Tipping,M.E. and Bishop,C.M. (1999) Probabilistic principal component analysis. J. R. Stat. Soc. B (Stat. Methodol.), 61, 611-622.
42. Velpula,K.K. et al. (2013) Combined targeting of PDK1 and EGFR triggers regression of glioblastoma by reversing the Warburg effect. Cancer Res., 73, 7277-7289.
43. Verhaak,R.G. et al. (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell, 17, 98-110.
44. Wang,J. et al. (2008) c-Myc is required for maintenance of glioma cancer stem cells. PLoS One, 3, e3769.
45. Watson,M. (2006) CoXpress: differential co-expression in gene expression data. BMC Bioinformatics, 7, 509.
46. Wen,P.Y. et al. (2012) Current clinical development of PI3K pathway inhibitors in glioblastoma. Neuro Oncol., 14, 819-829.
47. Yuan,M. and Lin,Y. (2007) Model selection and estimation in the Gaussian graphical model. Biometrika, 94, 19-35.
48. Zhang,B. et al. (2009) Differential dependency network analysis to identify condition-specific topological changes in biological networks. Bioinformatics, 25, 526-532.